BioHarvest Sciences to Showcase Botanical Synthesis Platform June 24 at BIO Convention
BHST•On June 24 at 11:45 AM in Theater 3 at the BIO International Convention in San Diego, BioHarvest Sciences will present its Botanical Synthesis™ platform. They aim to showcase pharmaceutical-grade precision and scalability, engage potential pharmaceutical and life science partners, and strengthen their CDMO pipeline for plant-based molecule development.
1. Presentation Details
BioHarvest Sciences is scheduled to deliver a company presentation on Wednesday, June 24 at 11:45 AM in Theater 3 during the BIO International Convention in San Diego. This session will highlight the company’s latest progress and strategic initiatives in Botanical Synthesis technology.
2. Botanical Synthesis Platform
The Botanical Synthesis™ platform enables the production of plant-derived compounds with pharmaceutical-grade precision, consistency, and commercial scalability. It supports applications in drug discovery, active pharmaceutical ingredients, and next-generation therapeutics without the need to grow the underlying plant.
3. Partnership Objectives
BioHarvest Sciences is leveraging the convention to engage with pharmaceutical and life science organizations for CDMO collaborations. The company intends to strengthen its business development pipeline and secure strategic agreements that could drive long-term value for shareholders.
